News and Press
Genetic Engineering and Biotechnology News Highlights ExpressTec System
Ventria’s ExpressTec system is highlighted in the February 15, 2013 issue of GEN. The article reviews some of the key technical, regulatory, and economic issues that pharmaceutical companies must consider when planning a plant-based biomanufacturing program. View the full-text article at www.genengnews.com/gen-articles/plant-based-protein-biomanufacturing/4734/
More Articles...
- Ventria Bioscience and University of Southern California Awarded Grant to Develop a Fusion Protein for the Treatment of Diabetes
- In Vivo Characterization of Optiferrin™ Recombinant Human Transferrin Demonstrates Functional Similarity to Serum-Derived Human Transferrin
- Ventria Bioscience Acquires Meristem Therapeutics’ Recombinant Lactoferrin Intellectual Property
- Study Shows Optiferrin™ Recombinant Human Transferrin Is Comparable to Serum-Derived or Mammalian-Expressed Transferrin
- Ventria Bioscience and University of Colorado at Denver Awarded Grant to Study Treatment of Acetaminophen Overdose-Induced Liver Failure
- CDC, Ventria Bioscience Collaborate on Rabies Vaccine Research
- Ventria Bioscience’s InVitria Division Awarded $1.5 Million Grant to Develop Superior System for Cell-Based Vaccine Production
- Ventria Bioscience to Participate in Business Partnering Program at 2012 BIO International Convention
